Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Centene Corporation is a diversified healthcare enterprise providing government-sponsored managed care services, primarily Medicaid, Medicare Advantage, and Health Insurance Marketplace plans across all 50 states. The company serves approximately 28 million members through state contracts and federal programs, with significant exposure to lower-income populations and government reimbursement rates. Recent financial deterioration reflects integration challenges, elevated medical loss ratios, and potential reserve inadequacies.
Centene receives fixed per-member-per-month (PMPM) capitation payments from state and federal governments to manage healthcare for enrolled populations. Profitability depends on maintaining medical loss ratios (MLR) below capitation rates - the company must accurately forecast and manage medical costs including hospital utilization, pharmacy spending, and specialty care. The business model relies on scale advantages in provider network negotiations, care management programs to reduce avoidable utilization, and sophisticated actuarial capabilities to price risk accurately during contract bidding. Government rate adequacy and timely supplemental payments for high-cost populations are critical to margins.
Medical loss ratio (MLR) performance versus guidance - any deviation of 50-100 basis points significantly impacts earnings given thin margins on $195B revenue base
State Medicaid contract wins, renewals, and rate adequacy - particularly in large states like California, Texas, Florida where single contracts can represent $5-10B annual revenue
Medicare Advantage Star Ratings and CMS reimbursement rate changes - Star Ratings drive quality bonus payments worth hundreds of millions annually
Marketplace enrollment trends and ACA subsidy policy changes - exchange membership highly sensitive to subsidy levels and competitive dynamics
Reserve development and prior period adjustments - given negative working capital model, reserve inadequacies create significant earnings volatility
Medicaid redetermination cliff - estimated 15-20 million nationwide disenrollments as pandemic-era continuous enrollment provisions ended in 2023-2024, with Centene potentially losing 2-4 million members and $8-15B revenue
Government reimbursement rate pressure - state budget constraints and federal deficit concerns create persistent downward pressure on Medicaid rates, while Medicare Advantage faces potential rate cuts or policy changes limiting program growth
Regulatory risk from MLR floors, prior authorization restrictions, and potential Medicaid expansion/contraction based on political environment - single policy changes can impact billions in revenue
Intense competition from UnitedHealth (Optum), Elevance (Anthem), Molina, and CVS/Aetna in Medicaid and Medicare Advantage contract bidding - competitors with integrated care delivery models (UnitedHealth's Optum) have structural cost advantages
Provider disintermediation risk as health systems develop direct-to-government contracting capabilities, particularly in Medicare Advantage through ACO REACH and other value-based models
Marketplace commoditization with limited differentiation beyond price, leading to margin compression and adverse selection risk
Reserve adequacy concerns - current negative net margin of -3.4% and deteriorating ROE of -27.7% suggest potential reserve deficiencies or integration issues from acquisitions
Goodwill impairment risk from $18-20B goodwill balance (estimated 40-45% of assets) related to Medicaid contract acquisitions - contract losses or margin deterioration could trigger write-downs
Working capital volatility - negative working capital model creates cash flow sensitivity to membership mix changes, claims payment timing, and state payment delays
moderate-high - Medicaid enrollment is counter-cyclical (rises during recessions as unemployment increases and individuals lose employer coverage), while Medicare Advantage and Marketplace enrollment are more stable. However, state budget pressures during downturns can lead to Medicaid rate cuts or delayed supplemental payments. Healthcare utilization patterns show modest pro-cyclical tendencies as elective procedures decline during economic stress, potentially improving MLRs temporarily. The company's government-sponsored focus provides revenue stability but exposes it to fiscal policy and state budget dynamics.
Rising interest rates have mixed effects: (1) Positive impact on investment income from $25-30B cash and investment portfolio, with each 100bp rate increase adding $250-300M annual income; (2) Negative impact on valuation multiples as healthcare stocks typically trade on P/E basis and higher discount rates compress multiples; (3) Minimal direct financing cost impact given moderate 0.87x debt/equity ratio and predominantly fixed-rate debt structure. Net effect is modestly positive to earnings but negative to valuation.
Moderate exposure through provider payment obligations and medical claims payable of $15-18B. The company maintains negative working capital model (receives premiums upfront, pays claims with lag), making liquidity management critical. Credit market stress could impact ability to refinance debt or access revolver, though investment-grade rating provides buffer. State government credit quality matters significantly - delayed Medicaid payments during state fiscal crises create working capital strain.
value - Currently trading at 0.1x price/sales and 1.0x price/book with 21.3% FCF yield despite negative earnings, attracting deep value investors betting on operational turnaround and mean reversion from depressed margins. The 44.5% six-month return suggests momentum traders have entered, but -26.6% one-year return and negative profitability deter growth and quality-focused investors. High FCF generation despite negative net income indicates non-cash charges or working capital benefits that value investors view as temporary.
high - Stock exhibits significant volatility driven by quarterly earnings surprises (MLR misses), state contract announcements, and policy uncertainty. Healthcare services stocks typically have betas of 0.8-1.2, but Centene's government concentration and recent operational issues likely push beta above 1.0. The 54.5% swing from six-month high to one-year low demonstrates elevated volatility relative to broader healthcare sector.